Clinical TrialsSearch results
Number of results: 204
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)
- prostate cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01
Other
- Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study
- acute promyelocytic leukemia
- Japan Adult Leukemia Study Group (JALSG)
- 2005-09-13